Saturday 17 October 2026
Export BACK’s income statement to Excel — free account
IMAC Holdings, Inc.
BACK Healthcare Medical Care Facilities
IMAC Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $72,100.00, down 99.6% from fiscal 2022. In the quarter to September 2025, revenue grew 34.2%, EPS grew 16.7% and free cash flow fell 30.9%, each against the same quarter a year earlier.
0.00
0.00
NaN
Follow BACK
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | 4 | 3 | 3 | 3 | 3 | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Altman Z-Score |
— | — | — | (0.59) | (0.92) | (0.30) | (6.94) | — | (73.66) |
P/S ratio |
2.49 | 2.49 | 2.49 | 0.77 | 1.32 | 1.79 | 0.34 | — | 1.22 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | (4.69) | (11.27) | (4.09) | (4.85) | (2.84) | (17.50) | — | (184.94) |
Beneish M-Score |
— | 33.75 | 13.98 | (1.02) | (2.21) | (3.03) | (3.01) | — | — |
P/Operating CF |
(85.58) | (85.58) | (85.58) | (9.12) | (8.56) | (13.88) | (2.63) | — | (1.75) |
P/B ratio |
0.00 | 0.00 | 0.00 | 1.46 | 2.16 | 1.43 | 1.17 | — | 0.00 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.43 | 1.24 | — | 0.00 |
EV/Sales |
2.58 | 2.58 | 2.58 | 0.89 | 1.27 | 1.31 | 0.30 | — | 0.98 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.93 | — | 0.00 |
EV/Operating CF |
(9.54) | (9.54) | (9.54) | (3.32) | (2.73) | (2.47) | (0.47) | — | (0.51) |
EV/FCF |
(5.09) | (5.09) | (5.09) | (2.64) | (2.67) | (2.27) | (0.46) | — | (0.64) |
Quick Ratio |
31.29 | 0.56 | 0.04 | 0.27 | 0.70 | 1.69 | 0.57 | 0.12 | 0.07 |
Current Ratio |
31.34 | 1.50 | 0.05 | 0.43 | 0.80 | 1.84 | 1.68 | 0.60 | 0.09 |
Net Debt/EBITDA |
3.64 | (0.48) | (0.20) | (0.41) | 0.13 | 0.86 | 0.07 | 0.04 | 0.09 |
Debt/Assets |
31.22% | 41.72% | 7.05% | 11.05% | 10.17% | 0.49% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.65 | 3.11 | (0.20) | 0.28 | 0.26 | 0.01 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.01 | 0.55 | 1.08 | 0.96 | 0.64 | 0.61 | 0.85 | 0.00 | 0.05 |
Operating CF/Net income |
2.31 | 7.64 | 0.59 | 0.63 | 1.08 | 0.72 | 0.56 | 0.29 | 0.26 |
Capex/Depreciation |
— | (7.17) | (2.43) | (0.68) | (0.19) | (0.34) | (0.16) | 2.48 | 0.00 |
Interest Coverage |
— | (33.64) | (23.09) | (23.93) | (11.61) | (20.03) | (3,699.09) | (51.00) | (8.29) |
| (50.29%) | (12.19%) | 162.40% | (324.45%) | (70.38%) | (81.83%) | (162.03%) | (489.85%) | 381.10% | |
| (26.44%) | (3.97%) | (49.44%) | (41.26%) | (27.60%) | (44.88%) | (95.60%) | (156.21%) | (891.19%) | |
ROIC |
0.00% | (99.09%) | 0.00% | (39.37%) | (56.77%) | (57.54%) | (190.28%) | 0.00% | 0.00% |
Return on Tangible Assets |
(24.56%) | (7.36%) | 31.07% | (3,184.90%) | (949.04%) | (163.27%) | (415.75%) | 1,269.93% | 216.00% |
Average Days of Receivables |
7,324.33 | 64.55 | 16.54 | 30.36 | 43.05 | 30.68 | 64.97 | — | 141.75 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | 0.00% |
Selling, General and Administrative Expense of Revenue |
308.00% | 200.00% | 129.34% | 113.83% | 127.60% | 146.38% | 41.20% | 0.00% | 7,475.87% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.57 | 0.45 | 0.44 | 0.38 | 0.02 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 2.59% | 3.05% | 3.97% | 2.75% | 0.00% | 49.10% |
Graham Net Nets |
(0.86) | (0.86) | (0.86) | (0.85) | (0.42) | (0.01) | 0.81 | — | (3.28) |
Graham Number |
0.00 | 0.00 | 121.19 | 0.00 | 0.00 | 0.00 | 0.00 | — | 22.97 |
Earnings Yield |
(22.71%) | (22.71%) | (22.71%) | (55.39%) | (30.10%) | (37.82%) | (337.71%) | — | (514.28%) |
Free Cash Flow Yield |
(20.32%) | (20.32%) | (20.32%) | (44.08%) | (36.23%) | (32.16%) | (193.74%) | — | (124.99%) |
Revenue per Share |
0.00 | 3.60 | 44.38 | 58.58 | 34.88 | 19.16 | 17.17 | 0.00 | 0.05 |
Operating CF per Share |
(0.12) | (2.00) | (11.98) | (15.76) | (16.29) | (10.11) | (10.92) | (2.51) | (2.01) |
Capex per Share |
0.00 | (2.17) | (10.46) | (4.08) | (1.00) | (0.89) | (0.28) | 0.90 | 0.00 |
Free Cash Flow per Share |
(0.12) | (4.17) | (22.44) | (19.84) | (17.29) | (11.00) | (11.20) | (1.61) | (2.01) |
Cash per Share |
0.18 | 0.59 | 1.29 | 1.45 | 7.13 | 9.48 | 0.81 | 0.20 | 0.32 |
Shareholders Equity per Share |
0.10 | 0.79 | (26.04) | 30.74 | 21.23 | 23.91 | 4.94 | (0.68) | (3.59) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.10 | 0.79 | (26.04) | 30.74 | 21.23 | 23.91 | 4.94 | (0.68) | (3.59) |
Free Cash Flow |
(0.88) | (0.91) | (3.39) | (5.12) | (6.36) | (8.26) | (10.55) | (1.79) | (3.16) |
Working Capital |
1.55 | 0.23 | (13.16) | (3.49) | (1.19) | 4.13 | 4.40 | (0.75) | (6.54) |
Capital Expenditures |
— | (0.47) | (1.58) | (1.05) | (0.37) | (0.67) | (0.26) | 1.00 | — |
Net Current Asset Value |
1.05 | (0.40) | (14.34) | (9.90) | (7.18) | (0.21) | 4.40 | (0.75) | (6.54) |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Capex to Sales |
0.00 | 0.60 | 0.24 | 0.07 | 0.03 | 0.05 | 0.02 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.21 | — | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 0.12 | 0.20 | 0.42 | 1.10 | 0.84 | 301.22 | 504.50 | 0.15 |
Cash ROIC |
(34.33%) | (109.21%) | 114.59% | (48.47%) | (51.13%) | (32.77%) | (194.93%) | 337.07% | 61.59% |
Accounts Receivable Turnover |
0.07 | 3.57 | 30.28 | 19.37 | 9.26 | 10.57 | 7.91 | — | 0.05 |
Accounts Payable Turnover |
6.29 | 37.37 | 9.60 | 7.20 | 6.19 | 7.87 | 11.42 | 0.00 | 0.19 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Average Days of Payables |
5.83 | 18.55 | 72.75 | 70.76 | 43.40 | 55.53 | 11.76 | 0.00 | 3,245.89 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | 0.00 |
Average Receivables |
0.22 | 0.22 | 0.22 | 0.78 | 1.39 | 1.36 | 2.05 | — | 1.45 |
Average Payables |
0.03 | 0.03 | 0.66 | 2.09 | 2.30 | 2.11 | 1.55 | 0.51 | 1.58 |
Average Assets |
1.44 | 1.44 | 6.18 | 15.75 | 20.08 | 23.49 | 19.16 | 6.11 | 1.37 |
Average Common Equity |
0.76 | 0.47 | (1.88) | 2.00 | 7.88 | 12.88 | 11.30 | 1.95 | (3.20) |
Columns are period end dates